0001179110-22-001332.txt : 20220216
0001179110-22-001332.hdr.sgml : 20220216
20220216164017
ACCESSION NUMBER: 0001179110-22-001332
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220214
FILED AS OF DATE: 20220216
DATE AS OF CHANGE: 20220216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Williamson Douglas J
CENTRAL INDEX KEY: 0001911501
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37977
FILM NUMBER: 22644150
MAIL ADDRESS:
STREET 1: AVADEL PHARMACEUTICALS PLC
STREET 2: 10 EARLSFORT TERRACE
CITY: DUBLIN
STATE: L2
ZIP: D02 T390
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVADEL PHARMACEUTICALS PLC
CENTRAL INDEX KEY: 0001012477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK
STREET 2: BALLYCOOLIN
CITY: DUBLIN
STATE: L2
ZIP: 15
BUSINESS PHONE: 636-449-1830
MAIL ADDRESS:
STREET 1: 16640 CHESTERFIELD GROVE ROAD
STREET 2: SUITE 200
CITY: CHESTERFIELD
STATE: MO
ZIP: 63005
FORMER COMPANY:
FORMER CONFORMED NAME: FLAMEL TECHNOLOGIES SA
DATE OF NAME CHANGE: 19960422
4
1
edgar.xml
FORM 4 -
X0306
4
2022-02-14
0
0001012477
AVADEL PHARMACEUTICALS PLC
AVDL
0001911501
Williamson Douglas J
C/O AVADEL PHARMACEUTICALS PLC
10 EARLSFORT TERRACE
DUBLIN 2
L2
D02 T380
IRELAND
0
1
0
0
Chief Medical Officer
Stock Option (Right to Buy)
6.6
2022-02-14
4
A
0
275000
0
A
2032-02-14
ADSs
275000
275000
D
Options become exercisable as to 68,750 ADSs on each of the first four anniversaries after the 2/14/2022 grant date.
The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.
/s/ Jerad G. Seurer, as Attorney-in-Fact
2022-02-16